Active vaccination can be effective as a post-exposure prophylaxis, but the rapidity of the immune response induced, relative to the incubation time of the pathogen, is critical. We show here that CD40mAb conjugated to antigen induces a more rapid specific antibody response than currently used immunological adjuvants, alum and monophosphoryl lipid ATM. © 2010 Bhagawati-Prasad et al; licensee BioMed Central Ltd.
CITATION STYLE
Bhagawati-Prasad, V. N. S., De Leenheer, E., Keefe, N. P., Ryan, L. A., Carlring, J., & Heath, A. W. (2010). CD40mAb adjuvant induces a rapid antibody response that may be beneficial in post-exposure prophylaxis. Journal of Immune Based Therapies and Vaccines, 8. https://doi.org/10.1186/1476-8518-8-1
Mendeley helps you to discover research relevant for your work.